Figure 2

Graphic representation of comparisons of efficacy and safety for each immunosuppressive treatment for IgA nephropathy. ((A)Supportive care; (B) Steroids; (C) Tacrolimus; (D) Mycophenolate mofetil; (E) Cyclophosphamide; (F) Azathioprine, (G) Cyclophosphamide + Azathioprine).